NexusTrade Loading NexusTrade… Taking too long? Reload this page

About FibroBiologics, Inc. Common Stock (FBLG)

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

Ticker
FBLG
Exchange
XNAS
Sector
Healthcare
Industry
Biotechnology

Company profile updated October 10, 2026.

Stored market snapshot

As of October 8, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$1.11
Company market capitalization (USD)
$7,390,594.23
Price / book
1.59×

Research FBLG

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: